Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.77 USD | +1.06% | +4.16% | +124.09% |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Mar. 13 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 2.02M | Sales 2023 | - | Capitalization | 23.43M |
---|---|---|---|---|---|
Net income 2022 | -19M | Net income 2023 | -20M | EV / Sales 2022 | 21.1 x |
Net cash position 2022 | 11.42M | Net cash position 2023 | 8.98M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.18
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.41% |
1 day | +1.06% | ||
1 week | +4.16% | ||
Current month | +9.52% | ||
1 month | +19.36% | ||
3 months | +226.82% | ||
6 months | +49.48% | ||
Current year | +124.09% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 22-12-07 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Srini Akkaraju
BRD | Director/Board Member | 56 | Feb. 26 |
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 25.77 | +1.06% | 1,576 |
24-04-24 | 25.5 | +2.10% | 5,602 |
24-04-23 | 24.98 | +2.21% | 4,442 |
24-04-22 | 24.44 | +1.64% | 2,994 |
24-04-19 | 24.04 | -2.83% | 3,519 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+124.09% | 62.69M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.03% | 22.02B | |
-17.84% | 20.9B | |
-9.33% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- VTVT Stock